STOCK TITAN

RRE Ventures Acquisition Corp. Units Form 4 Filings

RREVU NASDAQ

Every Form 4 that RRE Ventures Acquisition Corp. Units (RREVU) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow RREVU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RREVU filings page.

Rhea-AI Summary

RRE Ventures Acquisition Corp. reported that its 10% owner RRE Sponsor, LLC forfeited 1,250,000 Class B Ordinary Shares on May 14, 2026 for no consideration after underwriters waived their IPO over-allotment option. Following this change, the sponsor holds 5,585,333 Class B Ordinary Shares indirectly.

The Class B Ordinary Shares automatically convert into Class A Ordinary Shares at the time of the company’s initial business combination, or earlier at the sponsor’s option, on a one-for-one basis and have no expiration date. The sponsor is controlled by a three‑member board of managers, each of whom disclaims beneficial ownership except to the extent of any pecuniary interest.

Rhea-AI Summary

RRE Ventures Acquisition Corp. president Jeffrey Douglas Epstein reported awards of warrants and founder shares. He received 500,000 private placement warrants at a purchase price of $1.0000 per warrant, each exercisable for Class A Ordinary Shares at a conversion price of $11.5000.

He was also granted 450,000 Class B Ordinary Shares on March 2, 2026 and a further 150,000 Class B Ordinary Shares on March 18, 2026, bringing his Class B holdings to 600,000 shares. According to the filing, the Class B Ordinary Shares will automatically convert into Class A Ordinary Shares on a one-for-one basis upon the issuer’s initial business combination, or earlier at his option.

Rhea-AI Summary

RRE Ventures Acquisition Corp. director awards via affiliated LLC show compensation-style grants rather than open-market trades. Keegan Investment Holdings, LLC, an entity associated with director Brian Frederick Daly, received 250,000 private placement warrants at $1.00 each, exercisable for Class A Ordinary Shares at $11.50 per share after the company’s initial business combination. The same LLC also received 75,000 and then an additional 30,000 Class B Ordinary Shares, which are convertible into Class A Ordinary Shares on a one-for-one basis with no expiration.

Rhea-AI Summary

RRE Ventures Acquisition Corp. director Bruce Bernstein reported receiving equity awards in the form of warrants and Class B Ordinary Shares. On May 1, 2026, he was granted 250,000 warrants at $1.00 per warrant, each exercisable into one Class A Ordinary Share at a conversion price of $11.50 per share, bringing his warrant holdings to 250,000. Earlier awards of Class B Ordinary Shares on March 2, 2026 for 40,000 shares and on March 25, 2026 for 75,000 shares increased his Class B holdings to 115,000. The Class B shares automatically convert into Class A Ordinary Shares on a one-for-one basis at the time of the company’s initial business combination, or earlier at his option, while the private placement warrants become exercisable 30 days after that business combination and expire five years later.

Rhea-AI Summary

RRE Ventures Acquisition Corp. director Robert Scott Mancini reported awards of derivative securities linked to Class A Ordinary Shares. He received 250,000 warrants at $1.00 per warrant, each exercisable into one Class A share at an exercise price of $11.50 after the company’s initial business combination. He also received 75,000 and 40,000 Class B Ordinary Shares at no cost, which automatically convert into Class A shares on a one-for-one basis in connection with the initial business combination or earlier at his option.

Rhea-AI Summary

RRE Ventures Acquisition Corp. director and CEO Philip Kassin reported awards of warrants and convertible sponsor shares rather than open‑market trades. He received 250,000 private placement warrants at $1.00 per warrant, each exercisable for one Class A Ordinary Share at $11.50 per share. Earlier awards added 450,000 and 75,000 Class B Ordinary Shares, which are convertible into Class A on a one‑for‑one basis in connection with the company’s initial business combination. After these grants, he directly holds 250,000 warrants and 525,000 Class B shares, with no sales or dispositions reported.

Rhea-AI Summary

RRE Ventures Acquisition Corp. director James Steven Gertler reported compensation-related equity grants. He received 125,000 private placement warrants on May 1, 2026 at $1.00 per warrant, each exercisable for one Class A Ordinary Share at an exercise price of $11.50. He was also awarded 30,000 Class B Ordinary Shares on March 2, 2026 and a further 37,500 Class B Ordinary Shares on March 24, 2026, taking his Class B holdings to 67,500 shares. The Class B Ordinary Shares automatically convert into Class A Ordinary Shares on a one-for-one basis at the company’s initial business combination, or earlier at his option, and the private placement warrants become exercisable 30 days after that business combination and expire five years later or earlier upon liquidation.